References
- AlacaciogluASomaliISimsekIEpidemiology and survival of hepatocellular carcinoma in Turkey: outcome of multicenter studyJpn J Clin Oncol2008381068368818753360
- VillanuevaAMinguezBFornerAReigMLlovetJMHepatocellular carcinoma: novel molecular approaches for diagnosis, prognosis, and therapyAnnu Rev Med20106131732820059340
- YangJDRobertsLRHepatocellular carcinoma: A global viewNat Rev Gastroenterol Hepatol20107844845820628345
- TakeichiMCadherins: a molecular family essential for selective cell-cell adhesion and animal morphogenesisTrends Genet198738213217
- TakeichiMHattaKNoseANagafuchiAIdentification of a gene family of cadherin cell adhesion moleculesCell Differ Dev198825Suppl91943061598
- GumbinerBStevensonBGrimaldiAThe role of the cell adhesion molecule uvomorulin in the formation and maintenance of the epithelial junctional complexJ Cell Biol19881074157515873049625
- GumbinerBMRegulation of cadherin-mediated adhesion in morphogenesisNat Rev Mol Cell Biol20056862263416025097
- TakeichiMCadherin cell adhesion receptors as a morphogenetic regulatorScience19912515000145114552006419
- MareelMBoterbergTNoëVE-cadherin/catenin/cyto-skeleton complex: a regulator of cancer invasionJ Cell Physiol199717322712749365535
- PaduaDMassaguéJRoles of TGFbeta in metastasisCell Res20091918910219050696
- QianXKarpovaTSheppardAMMcnallyJLowyDRE-cadherin-mediated adhesion inhibits ligand-dependent activation of diverse receptor tyrosine kinasesEmbo J20042381739178415057284
- OzawaMBaribaultHKemlerRThe cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different speciesEmbo J198986171117172788574
- MendonsaAMNaTYGumbinerBME-cadherin in contact inhibition and cancerOncogene201837354769478029780167
- GiannelliGKoudelkovaPDituriFMikulitsWRole of epithelial to mesenchymal transition in hepatocellular carcinomaJ Hepatol201665479880827212245
- YoshiuraKKanaiYOchiaiAShimoyamaYSugimuraTHirohashiSSilencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomasProc Natl Acad Sci U S A19959216741674197543680
- GraffJRHermanJGLapidusRGE-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomasCancer Res19955522519551997585573
- HuangJCurrent progress in epigenetic research for hepatocarcinomagenesisSci China C Life Sci2009521314219152082
- YangBGuoMHermanJGClarkDPAberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinomaAm J Pathol200316331101110712937151
- WellsGASheaBO’ConnellDThe Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-AnalysesOttawa, ONOttawa Hospital Research Institute2013
- GyorffyBSurowiakPBudcziesJLanczkyAOnline survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancerPLoS One8e82241
- EggerMDavey SmithGSchneiderMMinderCBias in meta-analysis detected by a simple, graphical testBMJ199731571096296349310563
- van RoyFBerxGThe cell-cell adhesion molecule E-cadherinCell Mol Life Sci200865233756378818726070
- BerxGvan RoyFInvolvement of members of the cadherin superfamily in cancerCold Spring Harb Perspect Biol200916a00312920457567
- RodriguezFJLewis-TuffinLJAnastasiadisPZE-cadherin’s dark side: possible role in tumor progressionBiochim Biophys Acta201218261233122440943
- KanaiYUshijimaSHuiAMThe E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomasInt J Cancer19977133553599139867
- SchagdarsurenginUWilkensLSteinemannDFrequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinomaOncogene200322121866187112660822
- OhBKKimHParkHJDNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlationInt J Mol Med2007201657317549390
- SaitoYKanaiYNakagawaTIncreased protein expression of DNA methyltransferase (DNMT) 1 is significantly correlated with the malignant potential and poor prognosis of human hepatocellular carcinomasInt J Cancer2003105452753212712445
- BeumerJHPariseRANewmanEMConcentrations of the DNA methyltransferase inhibitor 5-fluoro-2′-deoxycytidine (FdCyd) and its cytotoxic metabolites in plasma of patients treated with FdCyd and tetrahydrouridine (THU)Cancer Chemother Pharmacol200862236336817899082
- GowherHJeltschAMechanism of inhibition of DNA methyl-transferases by cytidine analogs in cancer therapyCancer Biol Ther20043111062106815539938
- NewmanEMMorganRJKummarSA phase I, pharmacokinetic, and pharmacodynamic evaluation of the DNA methyltransferase inhibitor 5-fluoro-2′-deoxycytidine, administered with tetrahydrouridineCancer Chemother Pharmacol201575353754625567350
- GiannelliGBergaminiCFransveaESgarraCAntonaciSLaminin-5 with transforming growth factor-beta1 induces epithelial to mesenchymal transition in hepatocellular carcinomaGastroenterology200512951375138316285938
- GaoDVahdatLTWongSChangJCMittalVMicroenvironmental regulation of epithelial-mesenchymal transitions in cancerCancer Res201272194883488923002209
- LeeTKPoonRTYuenAPTwist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transitionClin Cancer Res200612185369537617000670
- ZekriARBahnasyAAShoeabFEMethylation of multiple genes in hepatitis C virus associated hepatocellular carcinomaJ Adv Res201451274025685469
- HerathNIPurdieDMKewMCVarying etiologies lead to different molecular changes in Australian and South African hepatocellular carcinomasInt J Oncol20093551081108919787262
- NishidaNNagasakaTNishimuraTIkaiIBolandCRGoelAAberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinomaHepatology200847390891818161048
- KatohHShibataTKokubuAEpigenetic instability and chromosomal instability in hepatocellular carcinomaAm J Pathol200616841375138416565510
- YuanYWangJLiJFrequent epigenetic inactivation of spleen tyrosine kinase gene in human hepatocellular carcinomaClin Cancer Res200612226687669517121887
- KwonGYYooBCKohKCChoJWParkWSParkCKPromoter methylation of E-cadherin in hepatocellular carcinomas and dysplastic nodulesJ Korean Med Sci200520224224715831995
- HerathNIWalshMDKewMCYoungJLeggettBAMacdonaldGACadherin/catenin complex appears to be intact in hepatocellular carcinomas from Australia and South AfricaJ Gastroenterol Hepatol200419667668215151624
- LeeSLeeHJKimJHLeeHSJangJJKangGHAberrant CpG island hypermethylation along multistep hepatocarcinogenesisAm J Pathol200316341371137814507645
- MatsumuraTMakinoRMitamuraKFrequent down-regulation of E-cadherin by genetic and epigenetic changes in the malignant progression of hepatocellular carcinomasClin Cancer Res20017359459911297254